PROCTER & GAMBLE HEALTH
Back to Cashflow Statement
|
PROCTER & GAMBLE HEALTH Last 5 Year Cash Flow from Financing Activities History
[Standalone]
| Mar2025 | Jun2024 | Mar2024 | Jun2023 | Jun2022 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-235 Cr | ₹-418 Cr | ₹-418 Cr | ₹-98 Cr | ₹-289 Cr |
What is the latest Cash Flow from Financing Activities ratio of PROCTER & GAMBLE HEALTH ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-235 Cr |
| Jun2024 | ₹-418 Cr |
| Mar2024 | ₹-418 Cr |
| Jun2023 | ₹-98 Cr |
| Jun2022 | ₹-289 Cr |
How is Cash Flow from Financing Activities of PROCTER & GAMBLE HEALTH Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-235 Cr | Negative | |
| Jun2024 | ₹-418 Cr | Negative | |
| Mar2024 | ₹-418 Cr | Negative | |
| Jun2023 | ₹-98 Cr | Negative | |
| Jun2022 | ₹-289 Cr | - | |
Compare Cash Flow from Financing Activities of peers of PROCTER & GAMBLE HEALTH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PROCTER & GAMBLE HEALTH | ₹10,034.5 Cr | 8.7% | 18.3% | 15.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹432,096.0 Cr | -2.4% | 3% | 9.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹176,807.0 Cr | -3.3% | 3.5% | 4.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹148,718.0 Cr | -2% | 5% | 43.1% | Stock Analytics | |
| CIPLA | ₹112,971.0 Cr | -0% | 6.9% | -4.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,752.0 Cr | -0.3% | -3.8% | 7.3% | Stock Analytics | |
PROCTER & GAMBLE HEALTH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PROCTER & GAMBLE HEALTH | 8.7% |
18.3% |
15.5% |
| SENSEX | -0.5% |
-3.3% |
-7.6% |
You may also like the below Video Courses